Research Site

Faro 8000-386

1 studies enrolling now · 5 studies all time

What they study most

Acute Coronary Syndrome, Anemia, Cardiovascular Disease, Congestive Heart Failure, Heart Failure, Hepatobiliary Cancers, Muscle Invasive Bladder Cancer, Stable Coronary Artery Disease (CAD), Myocardial Infarction, Ventricular Dysfunction

Studies at this site

• Observational Study Protocol: LIVER-R — Recruiting now
• Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin — Running, not enrolling
• RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial — Completed
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients — Stopped early